Common macrolide antibiotics show no increased risk of serious heart arrhythmia or death

February 22, 2016

Macrolide antibiotics such as azithromycin, clarithromycin and erythromycin are commonly used to treat respiratory tract infections worldwide, with more than 57 million outpatient prescriptions written in 2010 in the United States.

Previous studies show conflicting evidence as to whether these antibiotics increase the risk of a serious heart rhythm disturbance (ventricular arrhythmia) and death. Nonetheless, in 2013, the FDA issued a warning about these risks with macrolide antibiotics.

Canadian researchers conducted a matched study of over 600,000 adults aged 65 years or more in Ontario, Canada's largest province. They used data from the Institute for Clinical Evaluative Sciences (ICES) and universal prescription drug coverage data from the Ontario Health Insurance Plan (OHIP). The researchers matched people taking macrolide antibiotics with people of similar age, health status and other characteristics who were taking nonmacrolide antibiotics. Of the total study cohort, 57% were women, and the mean age was 74 years.

"We observed that, compared with nonmacrolide antibiotics, new use of macrolide antibiotics was associated with a similar 30-day risk of ventricular arrhythmia ... and a slightly lower risk of all-cause mortality," writes Dr. Amit Garg, director of the ICES western facility in London, Ontario, a physician at London Health Sciences Centre and a researcher at Lawson Health Research Institute.

No higher risk of adverse events with macrolide antibiotics compared to nonmacrolide antibiotics was observed in subsets of patients with congestive heart failure, coronary artery disease and chronic kidney disease.

"In contrast to prior studies, we found that these variables did not significantly alter the association between macrolide antibiotic use and our outcomes. Nonetheless, these findings should be interpreted with caution, and physicians should always consider a patient's baseline risk for adverse events before prescribing macrolides or other antibiotics."

"These findings are reassuring for health care providers who prescribe macrolide antibiotics to a wide range of patients in routine care," they conclude.
-end-


Canadian Medical Association Journal

Related Antibiotics Articles from Brightsurf:

Insights in the search for new antibiotics
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that addresses the gap in the discovery of new antibiotics.

New tricks for old antibiotics
The study published in the journal Immunity reveals that tetracyclines (broad spectre antibiotics), by partially inhibiting cell mitochondria activity, induce a compensatory response on the organism that decreases tissue damage caused during infection.

Benefits, risks seen with antibiotics-first for appendicitis
Antibiotics are a good choice for some patients with appendicitis but not all, according to study results published today in the New England Journal of Medicine.

How antibiotics interact
Understanding bottleneck effects in the translation of bacterial proteins can lead to a more effective combination of antibiotics / study in 'Nature Communications'

Are antivitamins the new antibiotics?
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

Hygiene reduces the need for antibiotics by up to 30%
A new paper published in the American Journal of Infection Control (AJIC), finds improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections by up to 50%, reducing the need for antibiotics, by up to 30%.

Antibiotics: City dwellers and children take the most
City dwellers take more antibiotics than people in rural areas; children and the elderly use them more often than middle-aged people; the use of antibiotics decreases as education increases, but only in rich countries: These are three of the more striking trends identified by researchers of the NRW Forschungskolleg ''One Health and Urban Transformation'' at the University of Bonn.

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

Antibiotics from the sea
The team led by Prof. Christian Jogler of Friedrich Schiller University, Jena, has succeeded in cultivating several dozen marine bacteria in the laboratory -- bacteria that had previously been paid little attention.

Antibiotics not necessary for most toothaches, according to new ADA guideline
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches.

Read More: Antibiotics News and Antibiotics Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.